Inside informationEnglish
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 07/01/2026, 18:02
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118159_20260107